-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G3VIwKJdhQrm3WBOzxKzz94c6EGlxDf2bI1RdfiLGXeIo4zex3aw1FYD+oQaw86j ZMVDHLiX8WbdCynp1Cv1Dg== 0000897069-03-000648.txt : 20030612 0000897069-03-000648.hdr.sgml : 20030612 20030612163206 ACCESSION NUMBER: 0000897069-03-000648 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030611 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP CENTRAL INDEX KEY: 0000070487 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 470634000 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29466 FILM NUMBER: 03742405 BUSINESS ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 4024752525 MAIL ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 8-K 1 irm365.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 _______________________ Date of Report (Date of earliest event reported): June 11, 2003 National Research Corporation ---------------------------------------------------- (Exact name of registrant as specified in its charter) Wisconsin 0-29466 47-0634000 - --------------- ---------------- -------------- (State or other (Commission File (IRS Employer jurisdiction of Number) Identification No.) incorporation) 1245 "Q" Street, Lincoln, Nebraska 68508 ---------------------------------------------------------- (Address of principal executive offices, including zip code) (402) 475-2525 ----------------------------- (Registrant's telephone number) Item 5. Other Events and Required FD Disclosure. - ------ --------------------------------------- On June 11, 2003, National Research Corporation issued a press release announcing a modification to its contract with HealthSouth Corporation and revising its earnings guidance for the second quarter of 2003. A copy of such press release is furnished as Exhibit 99 and is incorporated by reference herein. Item 7. Financial Statements and Exhibits. - ------ --------------------------------- (a) Not applicable. (b) Not Applicable. (c) Exhibits. The following exhibit is being furnished herewith: (99) Press Release of National Research Corporation, dated June 11, 2003. -2- SIGNATURES ---------- Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amendment to the report to be signed on its behalf by the undersigned hereunto duly authorized. NATIONAL RESEARCH CORPORATION Date: June 12, 2003 By: /s/ Patrick E. Beans --------------------------------------- Patrick E. Beans Vice President, Treasurer, Secretary and Chief Financial Officer -3- NATIONAL RESEARCH CORPORATION Exhibit Index to Current Report on Form 8-K Dated June 11, 2003 Exhibit Number - ------ (99) Press Release of National Research Corporation, dated June 11, 2003. -4- EX-99 3 irm365a.txt PRESS RELEASE [GRAPHIC OMITTED][NATIONAL RESEARCH CORPORATION LOGO] 1245 "Q" Street Lincoln, NE 68508 Phone: 402-475-2525 Fax: 402-475-9061 Contact: Patrick E. Beans Chief Financial Officer 402-475-2525 NATIONAL RESEARCH CORPORATION REVISES HEALTHSOUTH CONTRACT --------------------------------------------- Company Revises Previously Announced Second Quarter Guidance And Confirms Previously Announced Guidance for Third and Fourth Quarters of 2003 LINCOLN, Nebraska (June 11, 2003) -- National Research Corporation (NASDAQ/NM:NRCI), today announced that it has reached an agreement to modify the Company's current services contract with HealthSouth Corporation (formerly NYSE: HRC; now OTC: HLSH). The modification to the contract will help ensure HealthSouth remains a client, albeit at a reduced scope, by revising the payment terms and reducing by 50% the services provided by the Company to HealthSouth. As a result of the modified contract terms, National Research Corporation received $250,000 towards $350,000 in invoices relating to current services, and the Company will record a one-time charge in the second quarter of 2003 relating to the unpaid $100,000 balance. The Company is revising its previously announced guidance for the second quarter of 2003 from $0.16 per diluted share to $0.12 per diluted share as a result of the one-time charge and the reduction in the scope of the HealthSouth project. While revenue from the HealthSouth contract will remain reduced in the third and fourth quarters of 2003, the Company believes that new contracts currently being awarded from other sources will offset the reduction in revenue from HealthSouth. The Company expects second quarter 2003 revenue growth to meet its 25% growth target. Given revenue growth trends, the Company's previously announced guidance for the third and fourth quarters of 2003 remains $0.18 and $0.19 per diluted share, respectively. In addition, under the terms of the new HealthSouth contract, National Research Corporation will receive payment for future services in advance of services being performed, thus reducing payment risk for the Company. The scope of the project now reflects the minimum level of measurement mandatory for accreditation purposes, minimizing the risk for additional reduction. HealthSouth has also contractually agreed to name National Research Corporation as its sole and exclusive provider of patient satisfaction measurement for their facilities and is allowing the Company to contract directly with their individual facilities for additional patient satisfaction measurement beyond the minimum level required. National Research Corporation, headquartered in Lincoln, Nebraska, is a leading provider of ongoing survey-based performance measurement, analysis and tracking services to the healthcare industry. The Company addresses the growing need of healthcare providers and payors to measure the care outcomes, specifically satisfaction and health status, of their patients and/or members. This press release includes "forward-looking" statements related to the Company that can generally be identified as describing the Company's future plans, objectives or goals. Such forward-looking statements are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For further information about the factors that could affect the Company's future results, please see the Company's filings with the Securities and Exchange Commission. -END- -----END PRIVACY-ENHANCED MESSAGE-----